最後更新
成分股列表
Vanguard Health Care Index Fund(VHT) 成分股。透過此分析ETF所持有的個股有哪些，並可進一步分析個股的合理價與價值區間。
| 排名 | 代碼 | 名稱 | 比例 |
|---|---|---|---|
| 1 | LLY | Eli Lilly & Co. | 10.52% |
| 2 | UNH | UnitedHealth Group Inc. | 9.22% |
| 3 | ABBV | AbbVie Inc. | 4.79% |
| 4 | JNJ | Johnson & Johnson | 4.6% |
| 5 | MRK | Merck & Co. Inc. | 4.03% |
| 6 | ABT | Abbott Laboratories | 3.38% |
| 7 | TMO | Thermo Fisher Scientific Inc. | 3.31% |
| 8 | ISRG | Intuitive Surgical Inc. | 3.15% |
| 9 | DHR | Danaher Corp. | 2.55% |
| 10 | AMGN | Amgen Inc. | 2.49% |
| 11 | PFE | Pfizer Inc. | 2.43% |
| 12 | SYK | Stryker Corp. | 2.2% |
| 13 | BSX | Boston Scientific Corp. | 2.19% |
| 14 | VRTX | Vertex Pharmaceuticals Inc. | 1.98% |
| 15 | BMY | Bristol-Myers Squibb Co. | 1.96% |
| 16 | GILD | Gilead Sciences Inc. | 1.89% |
| 17 | MDT | Medtronic plc | 1.82% |
| 18 | CI | Cigna Corp. | 1.55% |
| 19 | ANTM | Anthem Inc. | 1.54% |
| 20 | REGN | Regeneron Pharmaceuticals Inc. | 1.33% |
| 21 | MCK | McKesson Corp. | 1.33% |
| 22 | ZTS | Zoetis Inc. | 1.3% |
| 23 | CVS | CVS Health Corp. | 1.23% |
| 24 | BDX | Becton Dickinson and Co. | 1.05% |
| 25 | HCA | HCA Healthcare Inc. | 1.04% |
| 26 | ABC | AmerisourceBergen Corp. Class A | 0.73% |
| 27 | EW | Edwards Lifesciences Corp. | 0.7% |
| 28 | A | Agilent Technologies Inc. | 0.65% |
| 29 | GEHC | GE HealthCare Technologies Inc. | 0.62% |
| 30 | IQV | IQVIA Holdings Inc. | 0.6% |
| 31 | RMD | ResMed Inc. | 0.6% |
| 32 | HUM | Humana Inc. | 0.58% |
| 33 | IDXX | IDEXX Laboratories Inc. | 0.57% |
| 34 | VEEV | Veeva Systems Inc. Class A | 0.57% |
| 35 | ALNY | Alnylam Pharmaceuticals Inc. | 0.53% |
| 36 | CNC | Centene Corp. | 0.52% |
| 37 | DXCM | DexCom Inc. | 0.51% |
| 38 | CAH | Cardinal Health Inc. | 0.48% |
| 39 | MTD | Mettler-Toledo International Inc. | 0.44% |
| 40 | WST | West Pharmaceutical Services Inc. | 0.39% |
| 41 | BIIB | Biogen Inc. | 0.38% |
| 42 | ILMN | Illumina Inc. | 0.38% |
| 43 | ZBH | Zimmer Biomet Holdings Inc. | 0.37% |
| 44 | WAT | Waters Corp. | 0.37% |
| 45 | STE | STERIS plc | 0.35% |
| 46 | COO | Cooper Cos. Inc. | 0.34% |
| 47 | LH | Labcorp Holdings Inc. | 0.33% |
| 48 | NTRA | Natera Inc. | 0.32% |
| 49 | PODD | Insulet Corp. | 0.31% |
| 50 | HOLX | Hologic Inc. | 0.3% |
| 51 | DGX | Quest Diagnostics Inc. | 0.3% |
| 52 | MOH | Molina Healthcare Inc. | 0.29% |
| 53 | BAX | Baxter International Inc. | 0.28% |
| 54 | ALGN | Align Technology Inc. | 0.27% |
| 55 | VTRS | Viatris Inc. | 0.26% |
| 56 | UTHR | United Therapeutics Corp. | 0.26% |
| 57 | MRNA | Moderna Inc. | 0.23% |
| 58 | PKI | PerkinElmer Inc. | 0.23% |
| 59 | AVTR | Avantor Inc. | 0.22% |
| 60 | THC | Tenet Healthcare Corp. | 0.22% |
| 61 | BMRN | BioMarin Pharmaceutical Inc. | 0.21% |
| 62 | NBIX | Neurocrine Biosciences Inc. | 0.21% |
| 63 | INCY | Incyte Corp. | 0.2% |
| 64 | TECH | Bio-Techne Corp. | 0.2% |
| 65 | UHS | Universal Health Services Inc. Class B | 0.2% |
| 66 | INSM | Insmed Inc. | 0.2% |
| 67 | EXAS | Exact Sciences Corp. | 0.19% |
| 68 | CTLT | Catalent Inc. | 0.18% |
| 69 | RPRX | Royalty Pharma plc Class A | 0.17% |
| 70 | CRL | Charles River Laboratories International Inc. | 0.17% |
| 71 | EHC | Encompass Health Corp. | 0.17% |
| 72 | PCVX | Vaxcyte Inc. | 0.17% |
| 73 | SOLV | Solventum Corp. | 0.17% |
| 74 | HSIC | Henry Schein Inc. | 0.16% |
| 75 | TFX | Teleflex Inc. | 0.15% |
| 76 | PEN | Penumbra Inc. | 0.15% |
| 77 | MEDP | Medpace Holdings Inc. | 0.15% |
| 78 | EXEL | Exelixis Inc. | 0.15% |
| 79 | SRPT | Sarepta Therapeutics Inc. | 0.14% |
| 80 | HQY | HealthEquity Inc. | 0.14% |
| 81 | ENSG | Ensign Group Inc. | 0.14% |
| 82 | RGEN | Repligen Corp. | 0.13% |
| 83 | CHE | Chemed Corp. | 0.13% |
| 84 | MASI | Masimo Corp. | 0.13% |
| 85 | ITCI | Intra-Cellular Therapies Inc. | 0.13% |
| 86 | GKOS | Glaukos Corp. | 0.13% |
| 87 | JAZZ | Jazz Pharmaceuticals plc | 0.12% |
| 88 | GMED | Globus Medical Inc. | 0.12% |
| 89 | DVA | DaVita Inc. | 0.12% |
| 90 | BIO | Bio-Rad Laboratories Inc. Class A | 0.11% |
| 91 | ELAN | Elanco Animal Health Inc. | 0.11% |
| 92 | RVMD | REVOLUTION Medicines Inc. | 0.11% |
| 93 | HALO | Halozyme Therapeutics Inc. | 0.1% |
| 94 | BRKR | Bruker Corp. | 0.1% |
| 95 | LNTH | Lantheus Holdings Inc. | 0.1% |
| 96 | MMSI | Merit Medical Systems Inc. | 0.1% |
| 97 | CYTK | Cytokinetics Inc. | 0.1% |
| 98 | BPMC | Blueprint Medicines Corp. | 0.1% |
| 99 | DOCS | Doximity Inc. Class A | 0.1% |
| 100 | INSP | Inspire Medical Systems Inc. | 0.09% |
| 101 | Corcept Therapeutics Inc. | 0.09% | |
| 102 | Hims & Hers Health Inc. | 0.09% | |
| 103 | Viking Therapeutics Inc. | 0.09% | |
| 104 | IONS | Ionis Pharmaceuticals Inc. | 0.08% |
| 105 | Integer Holdings Corp. | 0.08% | |
| 106 | RadNet Inc. | 0.08% | |
| 107 | TG Therapeutics Inc. | 0.08% | |
| 108 | Crinetics Pharmaceuticals Inc. | 0.08% | |
| 109 | PROCEPT BioRobotics Corp. | 0.08% | |
| 110 | ADMA Biologics Inc. | 0.08% | |
| 111 | ROIV | Roivant Sciences Ltd. | 0.08% |
| 112 | Organon & Co. | 0.07% | |
| 113 | Dentsply Sirona Inc. | 0.07% | |
| 114 | Option Care Health Inc. | 0.07% | |
| 115 | Haemonetics Corp. | 0.07% | |
| 116 | CRISPR Therapeutics AG | 0.07% | |
| 117 | Alkermes plc | 0.07% | |
| 118 | Prestige Consumer Healthcare Inc. | 0.07% | |
| 119 | Ultragenyx Pharmaceutical Inc. | 0.07% | |
| 120 | Krystal Biotech Inc. | 0.07% | |
| 121 | MDGL | Madrigal Pharmaceuticals Inc. | 0.07% |
| 122 | Guardant Health Inc. | 0.07% | |
| 123 | Acadia Healthcare Co. Inc. | 0.06% | |
| 124 | Perrigo Co. plc | 0.06% | |
| 125 | Envista Holdings Corp. | 0.06% | |
| 126 | ICU Medical Inc. | 0.06% | |
| 127 | CRVL | CorVel Corp. | 0.06% |
| 128 | Avidity Biosciences Inc. | 0.06% | |
| 129 | NUVL | Nuvalent Inc. Class A | 0.06% |
| 130 | Biohaven Ltd. | 0.06% | |
| 131 | Arrowhead Pharmaceuticals Inc. | 0.05% | |
| 132 | Amedisys Inc. | 0.05% | |
| 133 | Neogen Corp. | 0.05% | |
| 134 | LivaNova plc | 0.05% | |
| 135 | Denali Therapeutics Inc. | 0.05% | |
| 136 | PTC Therapeutics Inc. | 0.05% | |
| 137 | Twist Bioscience Corp. | 0.05% | |
| 138 | TransMedics Group Inc. | 0.05% | |
| 139 | Veracyte Inc. | 0.05% | |
| 140 | Agios Pharmaceuticals Inc. | 0.05% | |
| 141 | Axsome Therapeutics Inc. | 0.05% | |
| 142 | Vericel Corp. | 0.05% | |
| 143 | Bridgebio Pharma Inc. | 0.05% | |
| 144 | Rhythm Pharmaceuticals Inc. | 0.05% | |
| 145 | Arcellx Inc. | 0.05% | |
| 146 | Apellis Pharmaceuticals Inc. | 0.04% | |
| 147 | Premier Inc. Class A | 0.04% | |
| 148 | iRhythm Technologies Inc. | 0.04% | |
| 149 | Omnicell Inc. | 0.04% | |
| 150 | Inari Medical Inc. | 0.04% | |
| 151 | Select Medical Holdings Corp. | 0.04% | |
| 152 | Enovis Corp. | 0.04% | |
| 153 | CONMED Corp. | 0.04% | |
| 154 | Amicus Therapeutics Inc. | 0.04% | |
| 155 | Xenon Pharmaceuticals Inc. | 0.04% | |
| 156 | Addus HomeCare Corp. | 0.04% | |
| 157 | Ligand Pharmaceuticals Inc. | 0.04% | |
| 158 | NeoGenomics Inc. | 0.04% | |
| 159 | LeMaitre Vascular Inc. | 0.04% | |
| 160 | SpringWorks Therapeutics Inc. | 0.04% | |
| 161 | Merus NV | 0.04% | |
| 162 | Catalyst Pharmaceuticals Inc. | 0.04% | |
| 163 | QuidelOrtho Corp. | 0.04% | |
| 164 | UFP Technologies Inc. | 0.04% | |
| 165 | Geron Corp. | 0.04% | |
| 166 | Vera Therapeutics Inc. Class A | 0.04% | |
| 167 | Scholar Rock Holding Corp. | 0.04% | |
| 168 | SMMT | Summit Therapeutics Inc. | 0.04% |
| 169 | Novocure Ltd. | 0.03% | |
| 170 | Teladoc Health Inc. | 0.03% | |
| 171 | Integra LifeSciences Holdings Corp. | 0.03% | |
| 172 | Intellia Therapeutics Inc. | 0.03% | |
| 173 | Tandem Diabetes Care Inc. | 0.03% | |
| 174 | Brooks Automation Inc. | 0.03% | |
| 175 | Privia Health Group Inc. | 0.03% | |
| 176 | Beam Therapeutics Inc. | 0.03% | |
| 177 | 10X Genomics Inc. Class A | 0.03% | |
| 178 | Patterson Cos. Inc. | 0.03% | |
| 179 | ACADIA Pharmaceuticals Inc. | 0.03% | |
| 180 | AtriCure Inc. | 0.03% | |
| 181 | Supernus Pharmaceuticals Inc. | 0.03% | |
| 182 | Xencor Inc. | 0.03% | |
| 183 | Apollo Medical Holdings Inc. | 0.03% | |
| 184 | Celldex Therapeutics Inc. | 0.03% | |
| 185 | Amphastar Pharmaceuticals Inc. | 0.03% | |
| 186 | Iovance Biotherapeutics Inc. | 0.03% | |
| 187 | Surgery Partners Inc. | 0.03% | |
| 188 | Kymera Therapeutics Inc. | 0.03% | |
| 189 | National HealthCare Corp. | 0.03% | |
| 190 | MannKind Corp. | 0.03% | |
| 191 | Keros Therapeutics Inc. | 0.03% | |
| 192 | Sotera Health Co. | 0.03% | |
| 193 | Recursion Pharmaceuticals Inc. Class A | 0.03% | |
| 194 | Protagonist Therapeutics Inc. | 0.03% | |
| 195 | Akero Therapeutics Inc. | 0.03% | |
| 196 | RxSight Inc. | 0.03% | |
| 197 | Fortrea Holdings Inc. | 0.03% | |
| 198 | Ideaya Biosciences Inc. | 0.03% | |
| 199 | Mirum Pharmaceuticals Inc. | 0.03% | |
| 200 | Dynavax Technologies Corp. | 0.03% | |
| 201 | Dyne Therapeutics Inc. | 0.03% | |
| 202 | WaVe Life Sciences Ltd. | 0.03% | |
| 203 | Concentra Group Holdings Parent Inc. | 0.03% | |
| 204 | AMN Healthcare Services Inc. | 0.02% | |
| 205 | Progyny Inc. | 0.02% | |
| 206 | STAAR Surgical Co. | 0.02% | |
| 207 | BioCryst Pharmaceuticals Inc. | 0.02% | |
| 208 | Evolent Health Inc. Class A | 0.02% | |
| 209 | Arvinas Inc. | 0.02% | |
| 210 | Tilray Inc. | 0.02% | |
| 211 | Novavax Inc. | 0.02% | |
| 212 | Myriad Genetics Inc. | 0.02% | |
| 213 | Schrodinger Inc./United States | 0.02% | |
| 214 | Phreesia Inc. | 0.02% | |
| 215 | Certara Inc. | 0.02% | |
| 216 | Harmony Biosciences Holdings Inc. | 0.02% | |
| 217 | Travere Therapeutics Inc. | 0.02% | |
| 218 | US Physical Therapy Inc. | 0.02% | |
| 219 | Alignment Healthcare Inc. | 0.02% | |
| 220 | Syndax Pharmaceuticals Inc. | 0.02% | |
| 221 | CareDx Inc. | 0.02% | |
| 222 | Rocket Pharmaceuticals Inc. | 0.02% | |
| 223 | Aurinia Pharmaceuticals Inc. | 0.02% | |
| 224 | Innoviva Inc. | 0.02% | |
| 225 | Brookdale Senior Living Inc. | 0.02% | |
| 226 | BioLife Solutions Inc. | 0.02% | |
| 227 | Alphatec Holdings Inc. | 0.02% | |
| 228 | Collegium Pharmaceutical Inc. | 0.02% | |
| 229 | Viridian Therapeutics Inc. | 0.02% | |
| 230 | Clover Health Investments Corp. Class A | 0.02% | |
| 231 | CryoLife Inc. | 0.02% | |
| 232 | Immunovant Inc. | 0.02% | |
| 233 | Nurix Therapeutics Inc. | 0.02% | |
| 234 | Pennant Group Inc. | 0.02% | |
| 235 | MiMedx Group Inc. | 0.02% | |
| 236 | Amneal Pharmaceuticals Inc. | 0.02% | |
| 237 | Janux Therapeutics Inc. | 0.02% | |
| 238 | Embecta Corp. | 0.02% | |
| 239 | Tarsus Pharmaceuticals Inc. | 0.02% | |
| 240 | MEDNAX Inc. | 0.02% | |
| 241 | Disc Medicine Inc. | 0.02% | |
| 242 | Ardelyx Inc. | 0.02% | |
| 243 | ANI Pharmaceuticals Inc. | 0.02% | |
| 244 | MoonLake Immunotherapeutics Class A | 0.02% | |
| 245 | Harrow Inc. | 0.02% | |
| 246 | Apogee Therapeutics Inc. | 0.02% | |
| 247 | Arcutis Biotherapeutics Inc. | 0.02% | |
| 248 | Praxis Precision Medicines Inc. | 0.02% | |
| 249 | Edgewise Therapeutics Inc. | 0.02% | |
| 250 | Spyre Therapeutics Inc. | 0.02% | |
| 251 | Soleno Therapeutics Inc. | 0.02% | |
| 252 | WAY | Waystar Holding Corp. | 0.02% |
| 253 | BrightSpring Health Services Inc. | 0.02% | |
| 254 | Avadel Pharmaceuticals plc | 0.02% | |
| 255 | LifeStance Health Group Inc. | 0.02% | |
| 256 | GeneDx Holdings Corp. Class A | 0.02% | |
| 257 | agilon health Inc. | 0.01% | |
| 258 | Pacira BioSciences Inc. | 0.01% | |
| 259 | Prothena Corp. plc | 0.01% | |
| 260 | Maravai LifeSciences Holdings Inc. Class A | 0.01% | |
| 261 | Revance Therapeutics Inc. | 0.01% | |
| 262 | Pacific Biosciences of California Inc. | 0.01% | |
| 263 | Relay Therapeutics Inc. | 0.01% | |
| 264 | Vir Biotechnology Inc. | 0.01% | |
| 265 | AdaptHealth Corp. | 0.01% | |
| 266 | Ironwood Pharmaceuticals Inc. Class A | 0.01% | |
| 267 | CryoPort Inc. | 0.01% | |
| 268 | Cross Country Healthcare Inc. | 0.01% | |
| 269 | Owens & Minor Inc. | 0.01% | |
| 270 | Verve Therapeutics Inc. | 0.01% | |
| 271 | Arcus Biosciences Inc. | 0.01% | |
| 272 | Establishment Labs Holdings Inc. | 0.01% | |
| 273 | Avanos Medical Inc. | 0.01% | |
| 274 | Avid Bioservices Inc. | 0.01% | |
| 275 | Cytek Biosciences Inc. | 0.01% | |
| 276 | Anavex Life Sciences Corp. | 0.01% | |
| 277 | Emergent BioSolutions Inc. | 0.01% | |
| 278 | Allogene Therapeutics Inc. | 0.01% | |
| 279 | Varex Imaging Corp. | 0.01% | |
| 280 | Kura Oncology Inc. | 0.01% | |
| 281 | REGENXBIO Inc. | 0.01% | |
| 282 | OPKO Health Inc. | 0.01% | |
| 283 | DocGo Inc. | 0.01% | |
| 284 | uniQure NV | 0.01% | |
| 285 | Fulgent Genetics Inc. | 0.01% | |
| 286 | Adaptive Biotechnologies Corp. | 0.01% | |
| 287 | Mesa Laboratories Inc. | 0.01% | |
| 288 | Simulations Plus Inc. | 0.01% | |
| 289 | ImmunityBio Inc. | 0.01% | |
| 290 | Cerus Corp. | 0.01% | |
| 291 | Enhabit Inc. | 0.01% | |
| 292 | Accolade Inc. | 0.01% | |
| 293 | Cogent Biosciences Inc. | 0.01% | |
| 294 | OrthoPediatrics Corp. | 0.01% | |
| 295 | Vanda Pharmaceuticals Inc. | 0.01% | |
| 296 | HealthStream Inc. | 0.01% | |
| 297 | Theravance Biopharma Inc. | 0.01% | |
| 298 | Castle Biosciences Inc. | 0.01% | |
| 299 | SI-BONE Inc. | 0.01% | |
| 300 | Butterfly Network Inc. | 0.01% | |
| 301 | AngioDynamics Inc. | 0.01% | |
| 302 | Paragon 28 Inc. | 0.01% | |
| 303 | Sana Biotechnology Inc. | 0.01% | |
| 304 | AnaptysBio Inc. | 0.01% | |
| 305 | MaxCyte Inc. | 0.01% | |
| 306 | Replimune Group Inc. | 0.01% | |
| 307 | Surmodics Inc. | 0.01% | |
| 308 | Health Catalyst Inc. | 0.01% | |
| 309 | Arcturus Therapeutics Holdings Inc. | 0.01% | |
| 310 | SIGA Technologies Inc. | 0.01% | |
| 311 | Treace Medical Concepts Inc. | 0.01% | |
| 312 | Quanterix Corp. | 0.01% | |
| 313 | GoodRx Holdings Inc. Class A | 0.01% | |
| 314 | Ocugen Inc. | 0.01% | |
| 315 | Community Health Systems Inc. | 0.01% | |
| 316 | Orthofix Medical Inc. | 0.01% | |
| 317 | Phibro Animal Health Corp. Class A | 0.01% | |
| 318 | OraSure Technologies Inc. | 0.01% | |
| 319 | Nuvation Bio Inc. | 0.01% | |
| 320 | Erasca Inc. | 0.01% | |
| 321 | Stoke Therapeutics Inc. | 0.01% | |
| 322 | Humacyte Inc. | 0.01% | |
| 323 | MeiraGTx Holdings plc | 0.01% | |
| 324 | Phathom Pharmaceuticals Inc. | 0.01% | |
| 325 | Zimvie Inc. | 0.01% | |
| 326 | Monte Rosa Therapeutics Inc. | 0.01% | |
| 327 | Y-mAbs Therapeutics Inc. | 0.01% | |
| 328 | Pliant Therapeutics Inc. | 0.01% | |
| 329 | Altimmune Inc. | 0.01% | |
| 330 | Entrada Therapeutics Inc. | 0.01% | |
| 331 | OmniAb Inc. | 0.01% | |
| 332 | 89bio Inc. | 0.01% | |
| 333 | Day One Biopharmaceuticals Inc. | 0.01% | |
| 334 | Liquidia Technologies Inc. | 0.01% | |
| 335 | Terns Pharmaceuticals Inc. | 0.01% | |
| 336 | Evolus Inc. | 0.01% | |
| 337 | Enliven Therapeutics Inc. | 0.01% | |
| 338 | Fluidigm Corp. | 0.01% | |
| 339 | Cullinan Therapeutics Inc. | 0.01% | |
| 340 | Immunome Inc. | 0.01% | |
| 341 | Ocular Therapeutix Inc. | 0.01% | |
| 342 | EyePoint Pharmaceuticals Inc. | 0.01% | |
| 343 | Mind Medicine MindMed Inc. | 0.01% | |
| 344 | Zymeworks Inc. | 0.01% | |
| 345 | Astria Therapeutics Inc. | 0.01% | |
| 346 | Olema Pharmaceuticals Inc. | 0.01% | |
| 347 | ORIC Pharmaceuticals Inc. | 0.01% | |
| 348 | ARS Pharmaceuticals Inc. | 0.01% | |
| 349 | Savara Inc. | 0.01% | |
| 350 | Cargo Therapeutics Inc. | 0.01% | |
| 351 | GRAIL Inc. | 0.01% | |
| 352 | Kiniksa Pharmaceuticals International plc Class A | 0.01% | |
| 353 | PACS Group Inc. | 0.01% | |
| 354 | CG oncology Inc. | 0.01% | |
| 355 | Neumora Therapeutics Inc. | 0.01% | |
| 356 | Arbutus Biopharma Corp. | 0.01% | |
| 357 | ArriVent Biopharma Inc. | 0.01% | |
| 358 | Bioventus Inc. | 0.01% | |
| 359 | iRadimed Corp. | 0.01% | |
| 360 | Annexon Inc. | 0.01% | |
| 361 | Pulse Biosciences Inc. | 0.01% | |
| 362 | Sage Therapeutics Inc. | 0% | |
| 363 | Fate Therapeutics Inc. | 0% | |
| 364 | FibroGen Inc. | 0% | |
| 365 | Cassava Sciences Inc. | 0% | |
| 366 | Nevro Corp. | 0% | |
| 367 | ModivCare Inc. | 0% | |
| 368 | Zentalis Pharmaceuticals Inc. | 0% | |
| 369 | Seres Therapeutics Inc. | 0% | |
| 370 | Enanta Pharmaceuticals Inc. | 0% | |
| 371 | Editas Medicine Inc. | 0% | |
| 372 | American Well Corp. Class A | 0% | |
| 373 | Cutera Inc. | 0% | |
| 374 | Agenus Inc. | 0% | |
| 375 | 2seventy bio Inc. | 0% | |
| 376 | Multiplan Corp. | 0% | |
| 377 | Ventyx Biosciences Inc. | 0% | |
| 378 | Coherus Biosciences Inc. | 0% | |
| 379 | RAPT Therapeutics Inc. | 0% | |
| 380 | Alector Inc. | 0% | |
| 381 | Heron Therapeutics Inc. | 0% | |
| 382 | Atea Pharmaceuticals Inc. | 0% | |
| 383 | Pulmonx Corp. | 0% | |
| 384 | iTeos Therapeutics Inc. | 0% | |
| 385 | ATAI Life Sciences NV | 0% | |
| 386 | Repare Therapeutics Inc. | 0% | |
| 387 | Tango Therapeutics Inc. | 0% | |
| 388 | ALX Oncology Holdings Inc. | 0% | |
| 389 | MacroGenics Inc. | 0% | |
| 390 | IGM Biosciences Inc. | 0% | |
| 391 | Organogenesis Holdings Inc. Class A | 0% | |
| 392 | Aerovate Therapeutics Inc. | 0% | |
| 393 | HilleVax Inc. | 0% | |
| 394 | Outset Medical Inc. | 0% | |
| 395 | 23andMe Holding Co. Class A | 0% | |
| 396 | Definitive Healthcare Corp. Class A | 0% | |
| 397 | Biomea Fusion Inc. | 0% | |
| 398 | Amylyx Pharmaceuticals Inc. | 0% | |
| 399 | Aldeyra Therapeutics Inc. | 0% | |
| 400 | Lyell Immunopharma Inc. | 0% | |
| 401 | Cabaletta Bio Inc. | 0% | |
| 402 | Prime Medicine Inc. | 0% | |
| 403 | ACELYRIN Inc. | 0% | |
| 404 | Mural Oncology plc | 0% | |
| 405 | SCILEX HOLDING CO - RESTRICTED LINE | 0% | |
| 406 | 4D Molecular Therapeutics Inc. | 0% | |
| 407 | Korro Bio Inc. | 0% | |
| 408 | Dianthus Therapeutics Inc. | 0% | |
| 409 | Mineralys Therapeutics Inc. | 0% | |
| 410 | Perspective Therapeutics Inc. | 0% | |
| 411 | Lexicon Pharmaceuticals Inc. | 0% | |
| 412 | Rapport Therapeutics Inc. | 0% | |
| 413 | Tyra Biosciences Inc. | 0% | |
| 414 | Applied Therapeutics Inc. | 0% |
警語
1. 資料僅供參考，不做任何獲利保證及特定股票與點位推薦建議。
2. 資料並不完整，需要完整資料請至相關網站索取。
3. 任何股市數據分析皆存在倖存者偏差。
